http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-100974955-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4192 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D401-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D401-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-497 |
| filingDate | 2008-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2010-08-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-100974955-B1 |
| titleOfInvention | Piperazine derivatives having cycloalkyl pyrroles and azoles and salts thereof, and pharmaceutical compositions comprising the same |
| abstract | The present invention relates to a piperazine derivative having cycloalkyl pyrrole and azoles and salts thereof, and a pharmaceutical composition for preventing or treating mental disorders including the same, wherein the piperazine derivatives of the present invention exhibit excellent antagonistic action against dopamine D4 receptors. It can be usefully used as a prophylactic or therapeutic agent for mental disorders.n n n n n n n n n n Wheren n n R 1 is , egon n n Wherein X is hydrogen, halogen, C 1-6 alkyl, C 1-6 alkoxy or cyano;n n n R is hydrogen or phenyl substituted or unsubstituted with halogen, nitro, C 1-6 alkyl, C 1-6 alkoxy or cyano.);n n n R 2 is phenyl or benzyl, optionally substituted with halogen, C 1-6 alkyl, C 1-6 alkoxy or cyano;n n n n is an integer of 1-3. |
| priorityDate | 2008-02-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
| Predicate | Subject |
|---|---|
| isDiscussedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID466458477 |
Total number of triples: 14.